4th Quarter - Report
INDEPENDENT PHARMACY COOPERATIVE for INDEPENDENT PHARMACY COOPERATIVE
Income
—
Expenses
$10,000
Expense method
A: Lobbying Disclosure Act definitions
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Pharmacy PHA
CMS Average Manufacturer Price (AMP) Final Rule. Reporting by manufacturers and calculation. S. 274 The Medication Management Empowerment Act of 2011. All provisions S. 1002 Prohibit Theft of Medical Products 2011. All provisions. Potential prescription drug track-and-trace legislation. CMS Medicare Part B diabetic supply audits Region D. Concerns with scope and requirements of audit.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JIM DRISCOLL | — |
| MARK EUGENE KINNEY | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.